Conferences Neurocrine Biosciences is attending in 2026

LinkedIn neurocrine.com

Neurocrine Biosciences is listed at 3 conferences on Tnuki's calendar in 2026: AAPS 2026 PharmSci 360 (on the program), ACT 2026 (Gold Supporter) and Discovery on Target 2026 (on the attendee list). Neurocrine Biosciences is a biopharmaceutical company developing treatments for neurological, endocrine, and immunological disorders. As of Oct 20, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
AAPS 2026 PharmSci 360Pharmaceutical development scientistsOfficial site
New Orleans, LA ~4k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 symposiumAttending Sr. Principal Scientist
Open the guide Search and filter attendees
47th ACT Annual MeetingPharma & CRO nonclinical safety scientistsOfficial site
San Antonio, TX ~1.4k attendees ◇Gold SupporterAs published by American College of Toxicology Open the guide Search and filter attendees
Discovery on Target 2026Target discovery biologists & chemistsOfficial site
Past Boston, MA ~1.1k attendees On the attendee listNo booth or sponsorship in the organizer’s published lists
Listed in the Discovery on Target 2026 guide; no booth or program details yet
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Neurocrine Biosciences’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Neurocrine Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →